FEI 3012234942 of Maithri Drugs Private Limited | GDUFA | Fees | Self Identification | PharmaCompass.com

Please Wait

Applying Filters...

Maithri Drugs

Maithri Drugs

VIRTUAL BOOTH, Contact Details

DIGITAL CONTENT

2 Corporate Content #SupplierSpotlight, 2 Data Compilation #PharmaFlow

ACTIVE PHARMA INGREDIENTS

151 All APIs, 80 USDMF, 16 CEP/COS, 37 EU WC, 67 NDC API, 139 Listed APIs

KEY PRODUCTS

Acoramidis Hydrochloride, Aficamten, Atrasentan, Ensifentrine, Perfluorohexyloctane, Suzetrigine, Xanomeline

INSPECTIONS & REGISTRATIONS

8 FDA, 1 EDQM, 2 GDUFA, 1 Third-Party Audit

Xls

Filters

Filters

FILTER :

filter Registrant Name Reset all filters

1 All

01 1Maithri Drugs Private Limited

filter Facility Name Reset all filters

filter API Manufacture Reset all filters

List of Suppliers

Supplier Virtual Booth

price-trend

01

GDUFA fees paid

USA

InterContinental NY Barclay

Maithri Drugs: Dedicated to your API needs.

Paid in : 2025

Maithri Drugs

API Manufacturer : API MANUFACTURE

FDF Manufacturer :

Facility Name : Maithri Drugs Private Limited

Business Address : Sy. No. 205, 222 to 226, IDA...

FEI Number : 3012234942

Country : India

Paid in : 2025

Product
Web Link

Stock Recap
#PipelineProspector

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.